A citation-based method for searching scientific literature

Letitia D Jones, M Anthony Moody, Amelia B Thompson. Clin Ther 2020
Times Cited: 10







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Immune-correlates analysis of an HIV-1 vaccine efficacy trial.
Barton F Haynes, Peter B Gilbert, M Juliana McElrath, Susan Zolla-Pazner, Georgia D Tomaras, S Munir Alam, David T Evans, David C Montefiori, Chitraporn Karnasuta, Ruengpueng Sutthent,[...]. N Engl J Med 2012
40

Recent progress in broadly neutralizing antibodies to HIV.
Devin Sok, Dennis R Burton. Nat Immunol 2018
176
30

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
30

Neutralization tiers of HIV-1.
David C Montefiori, Mario Roederer, Lynn Morris, Michael S Seaman. Curr Opin HIV AIDS 2018
55
30

HIV-1 neutralizing antibodies: understanding nature's pathways.
John R Mascola, Barton F Haynes. Immunol Rev 2013
360
30

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Lawrence Corey, Peter B Gilbert, Michal Juraska, David C Montefiori, Lynn Morris, Shelly T Karuna, Srilatha Edupuganti, Nyaradzo M Mgodi, Allan C deCamp, Erika Rudnicki,[...]. N Engl J Med 2021
88
30

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities.
Yubin Liu, Wei Cao, Ming Sun, Taisheng Li. Emerg Microbes Infect 2020
30
30

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.
Xueling Wu, Zhi-Yong Yang, Yuxing Li, Carl-Magnus Hogerkorp, William R Schief, Michael S Seaman, Tongqing Zhou, Stephen D Schmidt, Lan Wu, Ling Xu,[...]. Science 2010
30

Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.
Rui Kong, Kai Xu, Tongqing Zhou, Priyamvada Acharya, Thomas Lemmin, Kevin Liu, Gabriel Ozorowski, Cinque Soto, Justin D Taft, Robert T Bailer,[...]. Science 2016
213
30

Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.
Charlotte Pollard, Joanna Rejman, Winni De Haes, Bernard Verrier, Ellen Van Gulck, Thomas Naessens, Stefaan De Smedt, Pieter Bogaert, Johan Grooten, Guido Vanham,[...]. Mol Ther 2013
126
20

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.
Luis A Brito, Michelle Chan, Christine A Shaw, Armin Hekele, Thomas Carsillo, Mary Schaefer, Jacob Archer, Anja Seubert, Gillis R Otten, Clayton W Beard,[...]. Mol Ther 2014
162
20

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Jeffrey M Jacobson, Jean-Pierre Routy, Seth Welles, Mark DeBenedette, Irina Tcherepanova, Jonathan B Angel, David M Asmuth, David K Stein, Jean-Guy Baril, Mehri McKellar,[...]. J Acquir Immune Defic Syndr 2016
57
20

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.
Sabine D Allard, Brenda De Keersmaecker, Anna L de Goede, Esther J Verschuren, Jeanette Koetsveld, Mariska L Reedijk, Carolien Wylock, Annelies V De Bel, Judith Vandeloo, Frank Pistoor,[...]. Clin Immunol 2012
71
20

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.
Jean-Pierre Routy, Mohamed-Rachid Boulassel, Bader Yassine-Diab, Charles Nicolette, Don Healey, Renu Jain, Claire Landry, Oleg Yegorov, Irina Tcherepanova, Tamara Monesmith,[...]. Clin Immunol 2010
82
20

Nonviral delivery of self-amplifying RNA vaccines.
Andrew J Geall, Ayush Verma, Gillis R Otten, Christine A Shaw, Armin Hekele, Kaustuv Banerjee, Yen Cu, Clayton W Beard, Luis A Brito, Thomas Krucker,[...]. Proc Natl Acad Sci U S A 2012
322
20

Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.
Rajesh T Gandhi, Douglas S Kwon, Eric A Macklin, Janet R Shopis, Anna P McLean, Nicole McBrine, Theresa Flynn, Lauren Peter, Amy Sbrolla, Daniel E Kaufmann,[...]. J Acquir Immune Defic Syndr 2016
52
20

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.
Willy M Bogers, Herman Oostermeijer, Petra Mooij, Gerrit Koopman, Ernst J Verschoor, David Davis, Jeffrey B Ulmer, Luis A Brito, Yen Cu, Kaustuv Banerjee,[...]. J Infect Dis 2015
88
20

mRNA vaccines - a new era in vaccinology.
Norbert Pardi, Michael J Hogan, Frederick W Porter, Drew Weissman. Nat Rev Drug Discov 2018
20



Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.
Yen Cu, Kate E Broderick, Kaustuv Banerjee, Julie Hickman, Gillis Otten, Susan Barnett, Gleb Kichaev, Niranjan Y Sardesai, Jeffrey B Ulmer, Andrew Geall. Vaccines (Basel) 2013
26
20

Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
Katalin Karikó, Hiromi Muramatsu, Frank A Welsh, János Ludwig, Hiroki Kato, Shizuo Akira, Drew Weissman. Mol Ther 2008
585
20

Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.
Kevin J Kauffman, Faryal F Mir, Siddharth Jhunjhunwala, James C Kaczmarek, Juan E Hurtado, Jung H Yang, Matthew J Webber, Piotr S Kowalski, Michael W Heartlein, Frank DeRosa,[...]. Biomaterials 2016
74
20



Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.
Norbert Pardi, Anthony J Secreto, Xiaochuan Shan, Fotini Debonera, Joshua Glover, Yanjie Yi, Hiromi Muramatsu, Houping Ni, Barbara L Mui, Ying K Tam,[...]. Nat Commun 2017
164
20

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
Kizzmekia S Corbett, Barbara Flynn, Kathryn E Foulds, Joseph R Francica, Seyhan Boyoglu-Barnum, Anne P Werner, Britta Flach, Sarah O'Connell, Kevin W Bock, Mahnaz Minai,[...]. N Engl J Med 2020
586
20

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques.
Norbert Pardi, Celia C LaBranche, Guido Ferrari, Derek W Cain, István Tombácz, Robert J Parks, Hiromi Muramatsu, Barbara L Mui, Ying K Tam, Katalin Karikó,[...]. Mol Ther Nucleic Acids 2019
43
20

Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.
Wesley de Jong, Lorna Leal, Jozefien Buyze, Pieter Pannus, Alberto Guardo, Maria Salgado, Beatriz Mothe, Jose Molto, Sara Moron-Lopez, Cristina Gálvez,[...]. Vaccines (Basel) 2019
14
20

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA.
Nathifa Moyo, Annette B Vogel, Søren Buus, Stephanie Erbar, Edmund G Wee, Ugur Sahin, Tomáš Hanke. Mol Ther Methods Clin Dev 2018
36
20

Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.
Cynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, Alicia Gamble, Whitney E Lewis, Anna B Cope, JoAnn D Kuruc, Kara S McGee, Mary F Kearney, John M Coffin,[...]. AIDS Res Hum Retroviruses 2018
34
20

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
Norbert Pardi, Michael J Hogan, Martin S Naradikian, Kaela Parkhouse, Derek W Cain, Letitia Jones, M Anthony Moody, Hans P Verkerke, Arpita Myles, Elinor Willis,[...]. J Exp Med 2018
199
20

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
Rogier W Sanders, Ronald Derking, Albert Cupo, Jean-Philippe Julien, Anila Yasmeen, Natalia de Val, Helen J Kim, Claudia Blattner, Alba Torrents de la Peña, Jacob Korzun,[...]. PLoS Pathog 2013
616
20

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
Susan P Buchbinder, Devan V Mehrotra, Ann Duerr, Daniel W Fitzgerald, Robin Mogg, David Li, Peter B Gilbert, Javier R Lama, Michael Marmor, Carlos Del Rio,[...]. Lancet 2008
20

Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.
Dennis R Burton, Lars Hangartner. Annu Rev Immunol 2016
352
20

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.
Marcella Sarzotti-Kelsoe, Robert T Bailer, Ellen Turk, Chen-li Lin, Miroslawa Bilska, Kelli M Greene, Hongmei Gao, Christopher A Todd, Daniel A Ozaki, Michael S Seaman,[...]. J Immunol Methods 2014
286
20

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Nicole A Doria-Rose, Chaim A Schramm, Jason Gorman, Penny L Moore, Jinal N Bhiman, Brandon J DeKosky, Michael J Ernandes, Ivelin S Georgiev, Helen J Kim, Marie Pancera,[...]. Nature 2014
515
20

Rapid evolution of the neutralizing antibody response to HIV type 1 infection.
Douglas D Richman, Terri Wrin, Susan J Little, Christos J Petropoulos. Proc Natl Acad Sci U S A 2003
925
20

Beyond antigens and adjuvants: formulating future vaccines.
Tyson J Moyer, Andrew C Zmolek, Darrell J Irvine. J Clin Invest 2016
203
20

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. N Engl J Med 2020
20

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.
Michael S Seaman, Holly Janes, Natalie Hawkins, Lauren E Grandpre, Colleen Devoy, Ayush Giri, Rory T Coffey, Linda Harris, Blake Wood, Marcus G Daniels,[...]. J Virol 2010
498
20


Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
Glenda E Gray, Linda-Gail Bekker, Fatima Laher, Mookho Malahleha, Mary Allen, Zoe Moodie, Nicole Grunenberg, Yunda Huang, Doug Grove, Brittany Prigmore,[...]. N Engl J Med 2021
45
20

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
20

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.
Johannes F Scheid, Hugo Mouquet, Niklas Feldhahn, Michael S Seaman, Klara Velinzon, John Pietzsch, Rene G Ott, Robert M Anthony, Henry Zebroski, Arlene Hurley,[...]. Nature 2009
677
20

Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions.
Tiza Ng'uni, Caroline Chasara, Zaza M Ndhlovu. Front Immunol 2020
21
20

Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.
Johannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, Ron Diskin, Florian Klein, Thiago Y K Oliveira, John Pietzsch, David Fenyo, Alexander Abadir, Klara Velinzon,[...]. Science 2011
846
20

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
Rebecca M Lynch, Eli Boritz, Emily E Coates, Adam DeZure, Patrick Madden, Pamela Costner, Mary E Enama, Sarah Plummer, Lasonji Holman, Cynthia S Hendel,[...]. Sci Transl Med 2015
307
20

The complex challenges of HIV vaccine development require renewed and expanded global commitment.
Linda-Gail Bekker, Roger Tatoud, Francois Dabis, Mark Feinberg, Pontiano Kaleebu, Mary Marovich, Thumbi Ndung'u, Nina Russell, Jeremiah Johnson, Maureen Luba,[...]. Lancet 2020
25
20

Progress in HIV vaccine development.
Denise C Hsu, Robert J O'Connell. Hum Vaccin Immunother 2017
52
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.